The Online Meeting on TURKOVAC with Azerbaijani Representatives
The preparations for the clinical studies of the first domestic and inactivated COVID-19 vaccine-named TURKOVAC, which was developed with the support of TÜSEB, have been made in Azerbaijan.
The Director of Turkish Vaccine Institute Prof. Dr. Ateş Kara, The Head of Project Management and Support Department Batuhan Yeşilyurt, The Head of Foreign Affairs Department Fatih Karademir, The Experts in TÜSEB Clinical Research Centre and Dr. Nurana Guliyeva and the accompanying delegation, who will coordinate the studies, attended the online meeting for the coordination of the studies.